Use

This test is useful for detecting disease-causing aerobic bacteria in specimens from patients with cystic fibrosis. It aids in determining the in vitro antimicrobial susceptibility of potentially pathogenic aerobic bacteria, which is crucial for appropriate treatment. The life expectancy of patients with CF has increased due to improved lung disease management, yet 75% to 85% of deaths in CF patients are due to chronic lung infections. Early and accurate detection of pathogens can lead to better management and outcomes.